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Abstract  
Background:  Radiofrequency  catheter  ablations  of  anteroseptal  (AS)  accessory  pathways 
(AP) in pediatric patients have higher incidence of atrioventricular (AV) block than other AP 
locations.  We report  our  experience  using  cryoablation  in  pediatric  patients  where  a  His 
bundle electrogram was noted on the ablation catheter at the site of the successful ablation.  
Methods  and Results:  We retrospectively  reviewed  all  patients  ≤21 years  that  underwent 
cryoablation for an AS AP from 2005 to 2012 at our institution (n=70).  Patients with a His 
bundle electrogram noted on the cryoablation catheter at the location of the successful lesion 
were identified (n=6, 8.5%).  All six patients had ventricular preexcitation. Median age of 15.9 
years (7.2 - 18.2). AV nodal function was monitored during the cryoablation with intermittent 
rapid atrial pacing conducted through the AV node (n=2), with atrial extra-stimulus testing 
(n=2),  or  during  orthodromic  reentrant  tachycardia  (n=2).  Acute  success  occurred  in  all 
patients.  Two patients had early recurrence of AP conduction.  Both patients underwent a 
second  successful  cryoablation,  again  with  a  His  bundle  electrogram  on  the  cryoablation 
catheter. At a median follow-up of 13 months (3 to 37 months) there was no recurrence of 
accessory  pathway  conduction  and  AVN  function  was  normal.              
Conclusions:  In  a  small  number  of  pediatric  patients  with  AS  AP  with  a  His  bundle 
electrogram seen on the ablation catheter, the use of cryotherapy was safe and effective for 
elimination  of  AP conduction  without  impairment  of  AV nodal  conduction.             
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Introduction
Electrophysiologic testing with catheter ablation of accessory pathways is indicated in some 
patients  with  Wolf-Parkinson-White  syndrome  or  as  an  elective  procedure  offered  as  an 
alternative to chronic antiarrhythmic drug therapy [1]. Ablation of accessory pathways located 
close to the conduction system are often challenging. Prior to the introduction of cryotherapy, 
ablation of anteroseptal pathways with radiofrequency energy  had a  lower  success  rate  than 
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other locations with high incidence of AV block [2, 3]. Although the use of cryoenergy had 
not significantly changed the acute success and recurrence rates after ablation of anteroseptal 
accessory pathways, it has certainly decreased the incidence of heart block [4]. It is possible 
that  the  success  rate  considering  intention  to  treat  anteroseptal  accessory  pathways  has 
increased  with  the  use  of  cryoenergy,  however  this  has  not  been  proven.  A  His  bundle 
electrogram at the ablation site has been used as a predictor for the development of AV block 
in  patients  undergoing  AV nodal  ablation  [5].  The  presence  of  a  His  bundle  electrogram 
during  ablation  of  parahisian  accessory  pathways  presents  a  challenge.  Ablation  using 
radiofrequency energy would not be delivered in such location in an elective ablation of an 
anteroseptal accessory pathway. Cryotherapy offers a safer alternative, since permanent heart 
block  has  not  been  described  using  this  technology.We  describe  our  experience  using 
cryotherapy for the ablation of parahisian accessory pathways with a His bundle electrogram 
seen  on  the  ablation  catheter  at  site  of  the  successful  ablation  location  and  describe  the 
techniques  used  to  monitor  atrioventricular  nodal  function  during  the  ablation.        
Methods
Study  Design                                                  
After Institutional Review Board approval, we performed a retrospective review of patients 
that underwent an electrophysiology study with ablation of an anteroseptal accessory pathway. 
Patients less than or equal to age 21 years who underwent a catheter ablation between 2005 
and  2012  were  included.  Patients  who  underwent  catheter  ablation  with  a  cryoablation 
catheter with a His bundle electrogram noted on the cryoablation catheter at the location of the 
successful  lesion  were  further  analyzed.                                          
Electrophysiology  Testing                                            
General  anesthesia  was  used  for  all  electrophysiology  studies.  Twelve-lead  surface 
electrocardiograms  and  bipolar  intracardiac  electrograms  filtered  at  30  to  500  Hz  were 
recorded at a rate of 200 mm/sec using a EP Workmate System (St Jude, West Berlin, NJ). 
Pacing  catheters  were  inserted  via  the  right  and left  femoral  veins  and  through  the  right 
internal  jugular  vein.  The  catheters  were  positioned  in  the  right  atrial  appendage,  right 
ventricular  apex, the His bundle area and within the coronary sinus.  Baseline intracardiac 
intervals, incremental atrial pacing, atrial extra-stimulus testing, incremental ventricular pacing 
and  ventricular  extra-stimulus  testing  were  performed  at  baseline  conditions  and  with  an 
infusion  of  isoproterenol  (0.01  to  0.02  μg/kg/min)  if  needed  to  induce  tachycardia.
Ablation  technique                                      
Mapping of the accessory pathway was performed using standard techniques [6]. Once the 
accessory pathway location was identified to be in the anteroseptal area the decision was made 
to use a cryocatheter (Medtronic, Inc. Minneapolis, MN) for the ablation. A 4 or 6 mm tip  
catheter was used and mapping of the anteroseptal area was performed from the right femoral 
vein or the right internal jugular vein (Figure 1). Once a target site was identified based on 
either a continuous atrioventricular signal in sinus or atrial paced rhythm or closely coupled 
local ventriculoatrial signal during orthodromic reentry tachycardia, pacing maneuvers were 
performed to determine the presence of a His bundle electrogram on the ablation catheter. The 
following pacing maneuvers were used: 1) rapid atrial pacing at a cycle length with conduction 
only via  the AV node, 2) atrial  extra-stimulus  testing with a  drive train of 4 beats  and a 
premature beat with a coupling interval shorter than the accessory pathway effective refractory 
period if conduction only via the AV node was seen at that coupling interval (Figure 2) or 3) 
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induction of orthodromic reentry tachycardia.  If a His bundle electrogram was seen in the 
chosen  location,  ablation  was  delivered  and  the  pacing  maneuvers  described  above  were 
repeated  during  the  cryo-application  to  monitor  AV nodal  function.  If  accessory  pathway 
conduction was not interrupted within 30 sec of freezing, the lesion was halted and the catheter 
repositioned. Once accessory pathway interruption was obtained a full 4 minute lesion was 
placed  and  at  least  two more  insurance  lesions  with  a  freeze-thaw-freeze  technique  were 
placed [7]. A His electrogram was seen in all the patients at the successful ablation location 
after the conduction of the accessory pathway was eliminated (Figure 3). Post ablation testing 
was performed for 30 minutes. Acute success was defined as no accessory pathway conduction 
at the end of the study. Recurrence of accessory pathway conduction at follow-up was defined 
as return of documented tachycardia or ventricular preexcitation on surface electrocardiogram.
 
Figure 1: Right anterior oblique (A) and left anterior oblique (B) views demonstrating proximity of the His  
catheter (His) and the ablation catheter (Abl).
Results
Demographic  and  EP  study  characteristics                                     
There  were  70  patients  with  an  anteroseptal  accessory  pathway  that  underwent  catheter 
ablation  during the study period;  six  patients  (8.5%) were identified  as  having had a  His 
bundle  electrogram  on  the  ablation  catheter  at  the  site  of  success,  all  with  ventricular 
preexcitation.  Four patients were male,the median age at the time of the ablation was 15.9 
years (range: 7.2 - 18.2) and the median weight was 68 kg (range: 23 - 82). At baseline, the 
mean PR interval measured 94 ± 8 msec, the AH interval was 69 ± 17 msec and the HV 
interval measured -25 ± 25 msec. The accessory pathway effective refractory period was 350 ± 
80 msec. Orthodromic reentry tachycardia was induced in 5 patients with a mean tachycardia 
cycle  length  of  348  ±  29  msec.                                          
Ablation  characteristics                                           
Acute  success  was  achieved  in  all  patients  (100% acute  success).  The  catheter  approach 
during  the  successful  lesion  was via  the  right  femoral  vein  in  four  patients  and the  right 
internal jugular vein in two. A long sheath was not used when approaching from the right 
femoral vein. Two patients were ablated with a 4 mm tip cryocatheter and four patients with a 
6 mm cryocatheter.  The median time from reaching a temperature of -70 Celsius to loss of 
accessory pathway conduction was 9.0 sec (range 1.3 to 14 seconds). AV nodal function was 
monitored during the cryoablation with rapid atrial pacing conducted only through the AV 
node (n=2), atrial  extra-stimulus testing (n=2), or during orthodromic reentrant tachycardia 
(n=2). One patient had transient complete AV block and another patient had AH prolongation 
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during  cryoablation,  both  resolved  immediately  after  discontinuation  of  the  refrigerant 
application.  The catheter was repositioned in one patient and moved from the right internal 
jugular vein to the right femoral vein in the second.  Again a His bundle was noted on the 
distal  ablation  catheter  and  further  lesions  were  delivered  with  elimination  of  accessory 
pathway conduction without heart block or AH prolongation in both patients.
  
Figure 2: Pacing maneuver during a cryo-application. Atrial extrastimulous testing at a drive train of 600 msec 
with an extrastimulus at 270 msec demonstrating conduction via the AV node. ECG leads I, II, aVF, V1, V6.  
HRA = high right atrium, AblD = distal ablation catheter, AblP = proximal ablation catheter, His = his catheter  
(D=  distal,  M=medial,  P=proximal),  RVA=  right  ventricular  apex,  Stim  =  stimulation  channel.          
 
  
Post  ablation  testing  showed  an  average  AH interval  of  71  ±  20  msec  (not  significantly 
different from prior to the ablation), HV time of 50 ± 7 msec (vs.  -25 ± 25 prior to ablation, 
p<0.01) and Wenckebach cycle length of 327 ± 37 msec. AV nodal function at the end of the 
case was normal in all patients.  After 30 minutes of testing,  adenosine was given in sinus 
rhythm  and  during  ventricular  pacing;  atrioventricular  and  ventriculoatrial  block  was 
demonstrated  in  all  patients  during  adenosine  administration.                      
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Follow  up  data                                              
Two patients had early recurrence of AP conduction,noted at 25 and 30 days after the acutely 
successful catheter ablation.  Both patients underwent a second successful cryoablation both 
utilizing  a  larger  tipped  catheter  (8mm),  again  with  a  His  bundle  electrogram  on  the 
cryoablation catheter. At a median follow-up of 13 months (range: 3 to 37 months) from the 
last  successful  catheter  ablation,  all  patients  were  asymptomatic  with  no  evidence  of 
ventricular  preexcitation  and  a  mean  PR  interval  of  155  ±  45  msec  on  the  surface 
electrocardiogram.
 
Figure 3: Panel A: signal at the site of success with a local AV time of 38 msec. The ventricular electrogram in  
the AblD is 55 msec prior to the initiation of the delta wave. Panel B: His electrogram seen on the ablation 
catheter  at  the  end  of  the  cryoapplication  (arrow).                                     
Discussion
Radiofrequency energy has been used for catheter ablation of accessory pathways in children 
for over 20 years [8]. The use of radiofrequency energy has proven to be safe and effective in 
eliminating  accessory  pathway  conduction.  However,  a  septal  location  of  the  accessory 
pathway carries a higher risk of damaging the conduction system during the ablation [3]. Prior 
reports  of  ablation  of  septal  accessory  pathways  using  radiofrequency  energy  have 
demonstrated a high acute success rate in eliminating accessory pathway conduction (94% - 
96%), however, the incidence of heart block was significant (3% to 5%)[2, 3, 9].On the other 
hand, other authors [10] reported no atrioventricular block at the expense of a slightly lower 
acute success rate (88%) for anteroseptal  accessory pathways; heart  block was avoided by 
moving the radiofrequency catheter 3 mm away from the largest His deflection.The presence 
of a His bundle electrogram on the ablation catheter has been shown to be associated with the 
development of AV block when conducting an ablation to intentionally cause heart block [5]. 
The electrophysiologist  might  not  be able  to  predict  if  a  radiofrequency lesion will  cause 
permanent damage of the conduction system, therefore, when mapping the anterior septal area, 
if a His bundle electrogram is found, it is general practice not to deliver radiofrequency energy 
in such a location. Since the introduction of transvenous catheter based cryotherapy, multiple 
studies have shown its efficacy in eliminating accessory pathway conduction without risk of 
permanent heart block [9, 11, 12]. Miyazaki et al described the use of cryotherapy for ablation 
of septal arrhythmia substrates; there were 4 patients in whom a His bundle electrogram was 
noted on the ablation catheter [13]. However, only one patient had an accessory pathway and 
there was no preexcitation, the other patients had AV nodal reentry or ventricular tachycardia. 
In our report, we found that in 8.5% of patients with anteroseptal accessory pathways, the 
pathway is extremely close to the atrioventricular node and the His bundle, such that on the 
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 14 (6): 284-290   (2014)
Liberman L et al, “Cryoablation of Anteroseptal Accessory Pathways”                             289
site of success a His bundle electrogram was recorded on the ablation catheter.                
In our retrospective review, we demonstrated that cryotherapy with a His bundle electrogram 
on the  ablation  catheter  can be done safely  without  permanent  damage of  the  conduction 
system. Care should be taken to monitor atrioventricular nodal conduction during the ablation, 
particularly in patients with ventricular preexcitation in which normal conduction might not be 
easily  seen.  Once  the  catheter  freezes  and  adheres  to  the  endocardial  surface,  pacing 
maneuvers  can  be  utilized  to  monitor  atrioventricular  nodal  conduction.  Our  techniques 
included the use of rapid atrial  pacing with conduction via the atrioventricular node, atrial 
extra-stimulus testing with a coupling interval shorter than the effective refractory period of 
the accessory pathway and ablation during orthodromic reentrant tachycardia. It is imperative 
that changes in atrioventricular nodal conduction are recognized quickly while the effect of the 
cryotherapy is still reversible. In terms of the catheter approach to the area, we have used both 
the right internal jugular vein and the right femoral vein with success from both approaches. 
Two  patients  had  recurrence  of  accessory  pathway  conduction.  Similarly,  Buddhe  et  al 
demonstrated a 33% recurrence rate after ablation of anteroseptal accessory pathways in a long 
term follow up study [14]. Both patients were successfully ablated during a second procedure 
using an 8 mm tip cryocatheter without complications. Perhaps consideration should be given 
to use a larger tip catheter on the first ablation attempt. Our study has the inherited limitations 
of a retrospective review of a small  number of patients.                                   
Conclusion
This report demonstrated that anteroseptal accessory pathways were safely and successfully 
ablated, in a small number of patients, using cryoenergy even when a His bundle electrogram 
is  recorded  from  the  tip  of  the  ablation  catheter.                                 
References
1. Friedman RA, Walsh EP, Silka MJ, Calkins H, Stevenson WG, Rhodes LA, Deal BJ, Wolff  
GS,  Demaso  DR,  Hanisch  D  and  Van  Hare  GF.  NASPE  Expert  Consensus  Conference: 
Radiofrequency Catheter  Ablation in Children with and without Congenital  Heart  Disease. 
Report  of  the  Writing  Committee.PACE 2002;  25:  1000 – 1017.                        
2.  Mandapati  R,  Berul  CI,  Triedman  JK,  Alexander  ME and  Walsh  EP.  Radiofrequency 
Catheter Ablation of Septal Accessory Pathways in the Pediatric Age Group. Am J Cardiol  
2003;  92:947-950.                                               
3. Van Hare GF, Javitz H, Carmelli D, Saul JP, Tanel RE, Fischbach PS, Kanter RJ, Schaffer  
M,  Dunnigan  A,  Colan  S,  Serwer  G  and  Participating  members  of  the  Pediatric 
Electrophysiology  Society.  Prospective  Assessment  after  Pediatric  Cardiac  Ablation: 
Demographics, Medical Profiles, and Initial Outcomes. J CardiovascElectrophysiol2004; 15: 
759-770.
4. Cohen MI, Triedman JK, Cannon BC, Davis AM, Drago F, Janousek J, Klein GJ, Law IH, 
Morady FJ,  Paul  T,  Perry JC,  Sanatani  S and Tanel  RE.  PACES/HRS Expert  Consensus 
Statement on the Management of the Asymptomatic Young Patient with a Wolff-Parkinson-
White  (WPW,  Ventricular  Preexcitation)  Electrocardiographic  Pattern.  Heart  Rhythm. 
2012;9(6):1006-24.
5. Gondo T, Yoshida T, Inage T, Takeuchi T, Fukoda Y, Takii E, Haraguchi G and Imaizumi 
T.  How  to  Avoid  Development  of  AV  block  during  RFAblation:  Anatomical  and 
Electrophysiological  Analysesat  the Time of  AV Node Ablation.  PACE 2012;  35:787-793
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 14 (6): 284-290   (2014)
Liberman L et al, “Cryoablation of Anteroseptal Accessory Pathways”                             290
6. Chugh A, Bogun F and Morady F: Catheter Ablation of Accessory Pathways. In Wilber DJ, 
Packer DL, Stevenson WG, eds:  Catheter  Ablation of Cardiac Arrhythmias.  Malden, MA: 
Blackwell  Futura,  2008, pp 172 -  149.                                                 
7. Bredikis A, Sidhu J. Critical  nitrogen cryo ablation: transmurality and effects of double 
freezing  cycle  in  chronic  experiment  (abstract).  Heart  Rhythm  2007;(Suppl.):PO5-62.
8. Van Hare GF, Lesh MD, Scheinman M and Langberg JJ. Percutaneous Radiofrequency 
Catheter Ablation for Supraventricular Arrhythmias in Children. JACC 1991; 17: 1613 - 1620.
9. Gatzoulis K, Apostolopoulos T, Costeas X, Sotiropoulos H, Papafanis F, Stefanadis C and 
Toutouzas P. Paraseptalaccessroy connections in the proximity of the atrioventricular node and 
the His bundle. Additional observations in the Relation to the ablation technique in a high risk 
area.Europace  2004; 6:  1 -  9.                                                           
10. Pecht B, Maginot KR, Boramanand NK and Perry JC. Techniques to avoid atrioventricular 
block  during  radiofrequency  catheter  ablation  of  septal  tachycardia  substrates  in  young 
patients.  J.  Interv Cardiac Electro  2002; 7:  83 -  88.                                      
11. Gaita F, Riccardi R, Hocini M, Haissaguerre M, Giustetto C, Jais P, Grossi S, Caruzzo E, 
Bianchi F and Richiardi E. Safety and efficacy of cryoablation of accessory pathways adjacent 
to  the  normal  conduction  system.  J  CardiovascElectrophysiol  2003;  14:  825  -  829. 
12.  Drago  F,  De  Santis  A,  Grutter  G  and  Silvetti  MS.  Transvenouscryothermal  catheter 
ablation  of  re-entry  circuit  near  the  atrioventricular  junction  in  pediatric  patients.  J.  Am 
CollCardiol 2005; 45: 1096 - 1103.                                                         
13. Miyazaki A, Blaufox AD, Fairbrother DL, Saul PJ. Cryo-ablation for Septal Tachycardia 
Substrates in Pediatric Patients. J Am Coll Cardiol 2005; 45: 581 – 588.                                   
14.  Buddhe  S,  Singh  H,  Du  W  and  Karpawich  PP.  Radiofrequency  and  Cryoablation 
Therapies for Supraventricular Arrhythmias in the Young: Five-Year Review of Efficacies. 
PACE 2012; 35:711 - 717.
Indian Pacing and Electrophysiology Journal (ISSN 0972-6292), 14 (6): 284-290   (2014)
